HALO:NASDAQ
Halozyme Therapeutics, Inc.
၁၁၀.၇၉ US$
arrow_upward
+၀.၉၈%(+၁.၀၇) 1D
၁၁၀.၀၀ US$
arrow_downward
-၀.၇၁% (-၀.၇၉)todayPre-market
Closed: အောက် ၇, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Open
၁၁၁.၆၂ US$
High
၁၁၄.၀၀ US$
Low
၁၁၀.၁၆ US$
Mkt. cap
ဋေ ၁.၂၆ ထ
Avg. vol.
၂.၂၃ သန်း
Volume
၇၄၈.၀၀
P/E ratio
၃၃.၁၀
52-wk high
၁၁၆.၈၄ US$
52-wk low
၆၁.၂၂ US$
EPS
၃.၃၅ US$
Beta
၀.၈၈
Shares outstanding
၁၁.၃၅ ကုဋေ
No. of employees
၄၂၃
Open
၁၁၁.၆၂ US$
High
၁၁၄.၀၀ US$
Low
၁၁၀.၁၆ US$
Mkt. cap
ဋေ ၁.၂၆ ထ
Avg. vol.
၂.၂၃ သန်း
Volume
၇၄၈.၀၀
P/E ratio
၃၃.၁၀
52-wk high
၁၁၆.၈၄ US$
52-wk low
၆၁.၂၂ US$
EPS
၃.၃၅ US$
Beta
၀.၈၈
Shares outstanding
၁၁.၃၅ ကုဋေ
No. of employees
၄၂၃
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
Barron's
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Merck’s Keytruda Is Dealt a Legal Setback. It’s Good News for This Biotech Stock.
Yahoo Finance Australia
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Halozyme stock rises after winning injunction against Merck
Investing.com
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Why is Halozyme Therapeutics stock climbing today?
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees၄၂၃
Founded၁၉၉၈
Headquartersဆန်ဒီရေဂို, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitehalozyme.com